DNA flow cytometry in surgically treated lung cancer. Prognostic significance

Scandinavian Cardiovascular Journal

Volumn 33, Issue 4, 1999, Pages 228-233

  Ikonen, Jari Tapio ^a   Ojala, Antti ^a   Salenius, Juha Pekka ^a   Mattila, Jorma ^a   Riekkinen, Heikki ^a   Wigren, Tuija ^a  

^a NONE

Author keywords

DNA aneuploidy; DNA index; Flow cytometry; Lung cancer; Nuclear DNA content

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CELL CYCLE S PHASE; COMPUTER PROGRAM; DIPLOIDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANEUPLOIDY; CELL CYCLE; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MALE; PLOIDIES; PROGNOSIS; S PHASE; SURVIVAL RATE;

EID: 0032833652     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017439950141669     Document Type: Article

References (38)

1. Chassevent A, Berruchon J, Bertrand G, et al. Flow DNA analysis in human lung cancer: potentiality and limitations due to sampling methods. Biol Cell 1986; 58: 121-126.
2. Kallioniemi OP. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988; 9: 164-169.
3. Kouri M, Pyrhonen S, Mecklin JP, et al. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990; 62: 976-981.
4. Merkel DE, McGuire WL. Ploidy, Proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 1990; 65: 1194-1205.
5. Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry 1985; 6: 348-356.
6. Volm M, Drings P, Kleine W, Mattern J. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas. Strahlentherapie und Onkologie 1987; 163: 791-694.
7. Haroske G, Kunze KD, Theissig F. Prognostic significance of image cytometry DNA parameters in tissue sections from breast and gastric cancers. Anal Cell Pathol 1991; 3: 11-24.
8. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T. Aneuploidy and high S-phase fraction are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 1987; 23: 277-282.
9. Lee AKC, Wiley B, Dugan JM, et al. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry. Path Res Pract 1992; 188: 428-432.
10. Longin A, Fontaniere B, Pinzani V, et al. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors. Pathol Res Pract 1992; 188: 466-472.
11. Weiss H, Kunde D, Streller B. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution. Arch Geschwulstforsch 1986; 56: 373-379.
12. Kallioniemi OP, Punnonen R, Mattila J, Lehtinen M, Koivula T. Prognostic significance of DNA-index, multiploidy and S-phase fraction in ovarian cancer. Cancer 1988; 61: 334-339.
13. Rutgers DH, Wils IS, Schaap AH, van-Lindert AC. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas. Pathol Res Pract 1987; 182: 207-213.
14. Jacobsen M, Hoyer M, Bentzen SM, Nielsen K. DNA flow cytometry in uterine endometrial carcinoma. APMIS 1991; 23 Suppl: 107-112.
15. Lindahl B, Gullberg B. Flow cytometrical DNA-and clinical parameters in the prediction of prognosis in stage I-II endometrial carcinoma. Anticancer Res 1991; 11: 397-401.
16. Hopman AH, Poddighe PJ, Smeets AW, et al. Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 1989; 135: 1105-1176.
17. Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T. Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 1991; 12: 413-421.
18. Visakorpi T, Kallioniemi OP, Paronen I, Isola J, Heikkinen A, Koivula T. Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinoma: implications for prognosis and response to endocrine therapy. Br J Cancer 1991; 64: 578-585.
19. Rofstad EK, Wahl A, Hystad ME, Nesland JM, Stokke T. Establishment in monolayer culture and characterization of four human melanoma cell lines. Virchows Arch B Cell Pathol 1991; 60: 189-197.
20. Rofstad EK, Wahl A, Stokke T, Nesland JM. Establishment and characterization of six human melanoma xenograft lines. APMIS 1990; 98: 945-953.
21. Sorensen FB, Kristensen IB, Grymer F, Jakobsen A. DNA-index and stereological estimation of nuclear volume in primary and metastatic malignant melanomas: a comparative study with analysis of heterogeneity. APMIS 1990; 98: 61-70.
22. Kallioniemi OP, Blanco G, Alavaikko M, et al. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987; 56: 637-642.
23. Visakorpi T. Cell proliferation rate in prostatic carcinoma: prognostic value and relation to epidermal growth factor receptor and p53 expression. Acta Univ Tamper 1992; Ser A Vol 342.
24. Bunn Jr PA, Carney DN, Gazdar AF, Whang-Peng J, Matthews MJ. Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res 1983; 43: 5026-5032.
25. Isobe H, Mieyamoto H, Shimizu T, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990; 65: 1391-1395.
26. Johnson TS, Valdivieso M, Barlogie B, Jefferies D, Williamson K, Keating M. Flow cytometric ploidy and proliferative activity in human small cell lung carcinomas: potential diagnostic and prognostic features (Abstr.) Proc Am Assoc Cancer Res 1982; 24: 124.
27. Macchiarini P, Fontanini G, Hardin J, Pingitore R, Angeletti A. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. J Thorac Cardiovasc Surg 1992; 104: 893-493.
28. Macchiarini P, Fontanini G, Hardin J, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1, N0, M0, non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993; 106: 81-89.
29. Miyamoto H, Harada M, Isobe H, et al. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Cancer Res 1991; 51: 6346-6350.
30. Ogawa J, Tsurumi T, Inoue H, Shohtsu A. Relationship between tumor DNA-ploidy and regional lymph node changes in lung cancer. Cancer 1992; 69: 1688-1695.
31. Ojala A, Kallioniemi OP, Wigren T, et al. Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncol 1990; 29: 983-988.
32. Sahin A, Ro JY, El-Naggar AK, et al. Flow cytometric analysis of the DNAcontent of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung. Cancer 1990; 65: 530-537.
33. Tirindelli-Danesi D, Teodori L, Mauro F, et al. Prognostic significance of flow cytometry in lung cancer. A 5-year study. Cancer 1987; 60: 844-851.
34. Ten Velde GPM, Schutte B, Vermeulen A, Volovics A, Reynders MMJ, Blijham GH. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. Eur J Cancer Clin Oncol 1988; 24: 455-460.
35. Visakorpi T, Holli K, Hakama M. High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma. Acta Oncol 1995; 34: 605-609.
36. Zimmerman PV, Hawson GAT, Bint MH, Parsons PG. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987; 5: 530-533.
37. Friedman PJ. Lung cancer; update on staging classifications. AJR Am J Roentgenol 1988; 150: 261-264.
38. WHO. Histological Typing of Lung Tumours. In: International Histological Classification of Tumours. No 1. Geneva: World Health Organisation, 1981.